Oyster Point Pharma, Inc. Contracts & Agreements
24 Contracts & Agreements
- Business Finance (8 contracts)
- Business Operations (1)
- Human Resources (11)
- Intellectual Property (1)
- Mergers & Acquisitions (1)
- Uncategorized (2)
- Agreement and Plan of Merger, dated as of November 7, 2022, by and among Viatris Inc., Iris Purchaser Inc. and Oyster Point Pharma, Inc (Filed With SEC on November 8, 2022)
- Form of Executive Employee Retention Equity and Bonus Letter (Filed With SEC on August 11, 2022)
- Form of Performance Stock Unit Grant Package (2019 Equity Incentive Plan) (Filed With SEC on February 24, 2022)
- Waiver and Amendment, dated as of October 19, 2021, by and among Oyster Point Pharma, Inc., OrbiMed Royalty & Credit Opportunities III, LP. and the other parties thereto (Filed With SEC on October 19, 2021)
- 2021 Inducement Plan (Filed With SEC on August 5, 2021)
- Form of Stock Option Grant Notice and Option Agreement for the 2021 Inducement Plan (Filed With SEC on August 5, 2021)
- Form of Restricted Stock Unit Grant Notice and (Filed With SEC on August 5, 2021)
- Outside Director Compensation Policy (Filed With SEC on February 18, 2021)
- Form of Underwriting Agreement, including Form of Lock-up Agreement (Filed With SEC on May 12, 2020)
- Description of Securities of the Registrant (Filed With SEC on February 27, 2020)
- Form of Underwriting Agreement, including Form of Lock-up Agreement (Filed With SEC on October 21, 2019)
- 2019 Equity Incentive Plan and forms of agreements thereunder, to be in effect upon the completion of this offering (Filed With SEC on October 21, 2019)
- 2019 Employee Stock Purchase Plan, to be in effect upon the completion of this offering (Filed With SEC on October 21, 2019)
- Non-Exclusive Patent License Agreement between the Registrant and Pfizer Inc., dated as of October 18, 2019 (Filed With SEC on October 21, 2019)
- Specimen common stock certificate of the Registrant (Filed With SEC on October 15, 2019)
- Amended and Restated Investor Rights Agreement among the Registrant and certain of its stockholders, dated February 15, 2019 (Filed With SEC on October 4, 2019)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on October 4, 2019)
- 2016 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on October 4, 2019)
- Employment Offer Letter between the Registrant and Jeffrey Nau, Ph.D., M.M.S (Filed With SEC on October 4, 2019)
- Employment Offer Letter between the Registrant and Daniel Lochner (Filed With SEC on October 4, 2019)
- Employment Offer Letter between the Registrant and John Snisarenko (Filed With SEC on October 4, 2019)
- Form of Change in Control and Severance Agreement (Filed With SEC on October 4, 2019)
- Outside Director Compensation Policy (Filed With SEC on October 4, 2019)
- Executive Incentive Compensation Plan (Filed With SEC on October 4, 2019)